Hemophagocytic lymphohistiocytosis in Egyptian children: diagnosis, treatment challenges, and outcome
Authors:
- 15 April 2024
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 17 (4-5) , 153-163
Abstract
Hemophagocyticlymphohistiocytosis (HLH) is a spectrum of immune activation which could be genetically determined, or secondaryto an underlying illness. Our aim was to present the clinico-genetic aspects ofHLH among Egyptian children and to evaluate the patterns of reactivation and outcomewith illustrations of overlap manifestations. We retrospectively collected the data of 55patients with HLH, registered at Ain Shams University Children's Hospital,Cairo, Egypt. Median age at diagnosis was 19 months (range 2-180), 33 patients (60%)fulfilled the diagnostic HLH criteria at presentation. Fourteen (25.45%) patients had secondary HLH, 15 (27.27%) patients had geneticallydocumented familial HLH (11 had variants in UNC13D gene and one in PRF1 gene), 3 had Griscelli and Chediak-Higashi syndrome. Sixteen patients (29.1%) had reactivations, 8(50%) of themhad molecularly confirmed HLH. Wereport the death of 40 patients, the median duration from the diagnosis todeath of 5 months mostly due to disease activity. This study confirms that the nonspecific signsand symptoms of HLH arechallenging. Genetic testing, though expensive and sophisticated, is integralfor the diagnosis. The difficulty in finding non-related donors for stem celltransplantation and the early reactivations are the causes of the inferioroutcome.Keywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale
- Lymphohistiocytose Famililale Espoir
This publication has 44 references indexed in Scilit:
- Current Updates on Classification, Diagnosis and Treatment of Hemophagocytic Lymphohistiocytosis (HLH)Indian Journal of Pediatrics, 2016
- Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015Journal of Clinical Immunology, 2015
- Prognostic factors of Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis in children: Report of the Japan Histiocytosis Study GroupPediatric Blood & Cancer, 2014
- Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in IndiaIndian Pediatrics, 2010
- HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 2006
- Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiencesCritical Reviews in Oncology/Hematology, 2005
- Cutaneous Manifestations of Hemophagocytic LymphohistiocytosisArchives of Dermatology, 2002
- Low natural killer activity and central nervous system disease as a high‐risk prognostic indicator in young patients with hemophagocytic lymphohistiocytosisCancer, 2002
- Macrophage Activation and Hemophagocytic Syndrome in Langerhans Cell Histiocytosis: Report of 30 CasesPediatric and Developmental Pathology, 2002
- Familial hemophagocytic lymphohistiocytosisEuropean Journal of Pediatrics, 1983